Cogent Biosciences Inc logo

Cogent Biosciences Inc

NAS:COGT (USA)  
$ 6.53 +0.685 (+11.74%) 11:08 PM EST
At Loss
P/B:
2.83
Market Cap:
$ 678.55M
Enterprise V:
$ 418.99M
Volume:
1.26M
Avg Vol (2M):
2.58M
Volume:
1.26M
At Loss
Avg Vol (2M):
2.58M

Business Description

Cogent Biosciences Inc logo
Cogent Biosciences Inc
NAICS : 325412 SIC : 2834
ISIN : US9032141049
Description
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
Name Current Vs Industry Vs History
Cash-To-Debt 14.09
Equity-to-Asset 0.82
Debt-to-Equity 0.07
Debt-to-EBITDA -0.09
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 54.96
9-Day RSI 49.05
14-Day RSI 48.58
6-1 Month Momentum % -23.65
12-1 Month Momentum % -27.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.09
Quick Ratio 7.09
Cash Ratio 6.96

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -38.6
Shareholder Yield % -0.23

Financials (Next Earnings Date:2024-05-09 Est.)

COGT's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:COGT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cogent Biosciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.41
Beta 0.03
Volatility % 78.6
14-Day RSI 48.58
14-Day ATR ($) 0.549781
20-Day SMA ($) 6.65075
12-1 Month Momentum % -27.77
52-Week Range ($) 3.67 - 13.5
Shares Outstanding (Mil) 103.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cogent Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Cogent Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cogent Biosciences Inc Frequently Asked Questions

What is Cogent Biosciences Inc(COGT)'s stock price today?
The current price of COGT is $6.53. The 52 week high of COGT is $13.50 and 52 week low is $3.67.
When is next earnings date of Cogent Biosciences Inc(COGT)?
The next earnings date of Cogent Biosciences Inc(COGT) is 2024-05-09 Est..
Does Cogent Biosciences Inc(COGT) pay dividends? If so, how much?
Cogent Biosciences Inc(COGT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1